MOVABEY Trademark

Trademark Overview


On Tuesday, June 25, 2019, a trademark application was filed for MOVABEY with the United States Patent and Trademark Office. The USPTO has given the MOVABEY trademark a serial number of 79265339. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, December 29, 2022. This trademark is owned by NOVARTIS AG. The MOVABEY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
movabey

General Information


Serial Number79265339
Word MarkMOVABEY
Filing DateTuesday, June 25, 2019
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, December 29, 2022
Registration Number5952508
Registration DateTuesday, January 7, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, December 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Saturday, January 14, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, January 14, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, February 28, 2020NOTIFICATION PROCESSED BY IB
Wednesday, February 12, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 12, 2020FINAL DISPOSITION PROCESSED
Thursday, February 6, 2020GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 7, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Saturday, October 19, 2019NOTIFICATION PROCESSED BY IB
Wednesday, October 2, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 2, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 13, 2019ASSIGNED TO EXAMINER
Wednesday, September 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 3, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, August 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 22, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 15, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB